 Dong Wang
Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellar Neoplasms | 2 | 2022 | 179 | 0.770 |
Why?
| | Medulloblastoma | 2 | 2022 | 218 | 0.750 |
Why?
| | Desoxycorticosterone Acetate | 1 | 2017 | 4 | 0.540 |
Why?
| | Relaxin | 1 | 2017 | 18 | 0.540 |
Why?
| | Glucosides | 1 | 2018 | 50 | 0.540 |
Why?
| | Benzhydryl Compounds | 1 | 2018 | 76 | 0.530 |
Why?
| | Kidney Diseases | 2 | 2018 | 409 | 0.510 |
Why?
| | Bile Acids and Salts | 5 | 2020 | 156 | 0.470 |
Why?
| | Liver Diseases | 1 | 2018 | 301 | 0.440 |
Why?
| | Acinar Cells | 5 | 2014 | 13 | 0.430 |
Why?
| | Heart | 1 | 2017 | 616 | 0.410 |
Why?
| | Glioma | 4 | 2022 | 418 | 0.400 |
Why?
| | Kidney | 2 | 2017 | 1482 | 0.380 |
Why?
| | Myocardium | 1 | 2017 | 911 | 0.370 |
Why?
| | Genome, Plant | 2 | 2008 | 30 | 0.350 |
Why?
| | Zinc Fingers | 2 | 2009 | 49 | 0.350 |
Why?
| | Oryza | 2 | 2008 | 29 | 0.350 |
Why?
| | Pancreas | 4 | 2014 | 326 | 0.330 |
Why?
| | Arabidopsis | 2 | 2008 | 91 | 0.330 |
Why?
| | Hypertension | 1 | 2017 | 1250 | 0.290 |
Why?
| | Diet, Western | 2 | 2020 | 81 | 0.280 |
Why?
| | Biliary Atresia | 2 | 2021 | 153 | 0.280 |
Why?
| | Obesity | 2 | 2018 | 3007 | 0.270 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2017 | 207 | 0.240 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2017 | 216 | 0.230 |
Why?
| | Diabetic Nephropathies | 2 | 2017 | 293 | 0.210 |
Why?
| | Cell Line, Tumor | 5 | 2022 | 3502 | 0.200 |
Why?
| | Brain Stem Neoplasms | 2 | 2021 | 83 | 0.200 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 2 | 2014 | 72 | 0.190 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 45 | 0.180 |
Why?
| | Liver | 3 | 2020 | 1821 | 0.180 |
Why?
| | Cell Proliferation | 4 | 2022 | 2502 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 65 | 0.180 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2021 | 19 | 0.170 |
Why?
| | Radiation Tolerance | 1 | 2022 | 104 | 0.170 |
Why?
| | Receptor, trkC | 1 | 2021 | 10 | 0.170 |
Why?
| | Pancreatitis | 2 | 2012 | 136 | 0.170 |
Why?
| | Receptor, trkB | 1 | 2021 | 35 | 0.170 |
Why?
| | Rhabdoid Tumor | 1 | 2022 | 100 | 0.170 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 55 | 0.170 |
Why?
| | Quinazolines | 1 | 2022 | 260 | 0.160 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.160 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2020 | 53 | 0.160 |
Why?
| | Transcriptional Elongation Factors | 1 | 2020 | 38 | 0.160 |
Why?
| | Immunoglobulin M | 1 | 2021 | 284 | 0.160 |
Why?
| | Piperazines | 1 | 2022 | 375 | 0.150 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2017 | 195 | 0.150 |
Why?
| | Apoptosis | 3 | 2022 | 2487 | 0.150 |
Why?
| | DNA Repair | 1 | 2021 | 240 | 0.150 |
Why?
| | Taurolithocholic Acid | 3 | 2014 | 3 | 0.150 |
Why?
| | Proto-Oncogene Proteins | 1 | 2022 | 621 | 0.140 |
Why?
| | Membrane Glycoproteins | 1 | 2021 | 490 | 0.140 |
Why?
| | Bile Ducts | 1 | 2018 | 67 | 0.140 |
Why?
| | Pyrazoles | 1 | 2022 | 482 | 0.140 |
Why?
| | Aging | 2 | 2020 | 1919 | 0.140 |
Why?
| | Animals | 14 | 2022 | 37328 | 0.140 |
Why?
| | Mice, Obese | 1 | 2018 | 65 | 0.140 |
Why?
| | Histones | 2 | 2020 | 641 | 0.140 |
Why?
| | Plant Proteins | 2 | 2009 | 111 | 0.140 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 628 | 0.140 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 528 | 0.140 |
Why?
| | Heart Function Tests | 1 | 2017 | 55 | 0.130 |
Why?
| | Urinalysis | 1 | 2017 | 78 | 0.130 |
Why?
| | Lipid Metabolism | 2 | 2020 | 522 | 0.130 |
Why?
| | Kidney Glomerulus | 1 | 2018 | 121 | 0.130 |
Why?
| | Kidney Function Tests | 1 | 2017 | 159 | 0.130 |
Why?
| | Kidney Tubules | 1 | 2017 | 117 | 0.130 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 263 | 0.130 |
Why?
| | Calcium Signaling | 3 | 2013 | 247 | 0.120 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 283 | 0.120 |
Why?
| | Mice, Inbred C57BL | 4 | 2020 | 5866 | 0.110 |
Why?
| | Renal Insufficiency | 1 | 2017 | 170 | 0.110 |
Why?
| | Genes, Plant | 3 | 2009 | 43 | 0.110 |
Why?
| | Oxidative Stress | 2 | 2018 | 1327 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 350 | 0.110 |
Why?
| | Electrocardiography | 1 | 2017 | 626 | 0.110 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1362 | 0.110 |
Why?
| | Mice | 11 | 2022 | 17969 | 0.100 |
Why?
| | Weight Gain | 1 | 2018 | 536 | 0.100 |
Why?
| | Antineoplastic Agents | 2 | 2022 | 2162 | 0.100 |
Why?
| | Autoantibodies | 1 | 2021 | 1466 | 0.100 |
Why?
| | Cytological Techniques | 1 | 2013 | 28 | 0.100 |
Why?
| | Adenoviridae Infections | 1 | 2013 | 19 | 0.100 |
Why?
| | Lipids | 1 | 2018 | 686 | 0.100 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2012 | 28 | 0.100 |
Why?
| | Mutation | 2 | 2021 | 4006 | 0.100 |
Why?
| | B-Lymphocytes | 1 | 2018 | 857 | 0.100 |
Why?
| | Secretory Vesicles | 1 | 2012 | 24 | 0.100 |
Why?
| | Calcineurin | 1 | 2012 | 107 | 0.090 |
Why?
| | Cytosol | 1 | 2012 | 225 | 0.090 |
Why?
| | Blood Pressure | 1 | 2017 | 1740 | 0.080 |
Why?
| | Cytokines | 1 | 2018 | 2079 | 0.080 |
Why?
| | Calcium | 2 | 2014 | 1175 | 0.080 |
Why?
| | Epigenomics | 2 | 2020 | 112 | 0.080 |
Why?
| | Inflammation | 2 | 2018 | 2840 | 0.080 |
Why?
| | Gossypium | 1 | 2009 | 1 | 0.080 |
Why?
| | Insulin Resistance | 1 | 2018 | 1221 | 0.080 |
Why?
| | Child | 4 | 2022 | 22390 | 0.070 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2009 | 67 | 0.070 |
Why?
| | Rats | 1 | 2017 | 5556 | 0.070 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2008 | 65 | 0.070 |
Why?
| | Chromosomes, Plant | 1 | 2008 | 8 | 0.070 |
Why?
| | RNA, Plant | 1 | 2008 | 9 | 0.070 |
Why?
| | Gene Duplication | 1 | 2008 | 65 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 849 | 0.070 |
Why?
| | Blood Glucose | 1 | 2018 | 2286 | 0.070 |
Why?
| | Amino Acid Motifs | 1 | 2008 | 223 | 0.070 |
Why?
| | Multigene Family | 1 | 2008 | 202 | 0.070 |
Why?
| | Sequence Alignment | 1 | 2008 | 363 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2008 | 389 | 0.070 |
Why?
| | Arabidopsis Proteins | 1 | 2008 | 72 | 0.070 |
Why?
| | Humans | 13 | 2022 | 141284 | 0.070 |
Why?
| | DNA Primers | 1 | 2008 | 507 | 0.060 |
Why?
| | Podocytes | 2 | 2017 | 69 | 0.060 |
Why?
| | Cholesterol | 2 | 2020 | 404 | 0.060 |
Why?
| | Phylogeny | 2 | 2008 | 997 | 0.060 |
Why?
| | Species Specificity | 1 | 2008 | 573 | 0.060 |
Why?
| | Male | 9 | 2021 | 70140 | 0.060 |
Why?
| | Chromatin | 2 | 2020 | 536 | 0.060 |
Why?
| | Biomarkers | 1 | 2017 | 4180 | 0.060 |
Why?
| | Signal Transduction | 2 | 2017 | 5116 | 0.060 |
Why?
| | Stress, Physiological | 1 | 2009 | 449 | 0.060 |
Why?
| | Child, Preschool | 4 | 2021 | 11511 | 0.060 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 1075 | 0.060 |
Why?
| | Carrier Proteins | 1 | 2009 | 738 | 0.060 |
Why?
| | RNA, Messenger | 3 | 2017 | 2815 | 0.050 |
Why?
| | Base Sequence | 1 | 2008 | 2170 | 0.050 |
Why?
| | Gene Expression | 1 | 2009 | 1490 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2008 | 2146 | 0.050 |
Why?
| | RNA-Binding Proteins | 1 | 2008 | 448 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2008 | 503 | 0.050 |
Why?
| | L-Lactate Dehydrogenase | 2 | 2014 | 113 | 0.050 |
Why?
| | Ryanodine | 2 | 2014 | 15 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2008 | 2911 | 0.050 |
Why?
| | Software | 1 | 2008 | 675 | 0.050 |
Why?
| | Radiation, Ionizing | 1 | 2022 | 80 | 0.050 |
Why?
| | Protein Isoforms | 2 | 2014 | 397 | 0.050 |
Why?
| | Disease Progression | 2 | 2021 | 2808 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1761 | 0.040 |
Why?
| | Portoenterostomy, Hepatic | 1 | 2021 | 42 | 0.040 |
Why?
| | Mitochondria | 2 | 2017 | 962 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 243 | 0.040 |
Why?
| | Teratoma | 1 | 2022 | 121 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2021 | 381 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2021 | 309 | 0.040 |
Why?
| | Lactobacillus | 1 | 2020 | 27 | 0.040 |
Why?
| | Cecum | 1 | 2020 | 32 | 0.040 |
Why?
| | Algorithms | 1 | 2008 | 1764 | 0.040 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2022 | 261 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2021 | 163 | 0.040 |
Why?
| | Astrocytoma | 1 | 2020 | 130 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 115 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 140 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 630 | 0.040 |
Why?
| | Gene Expression Regulation, Plant | 2 | 2009 | 53 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4414 | 0.040 |
Why?
| | Lysine | 1 | 2020 | 292 | 0.040 |
Why?
| | Chenodeoxycholic Acid | 1 | 2017 | 12 | 0.030 |
Why?
| | Cholic Acids | 1 | 2017 | 13 | 0.030 |
Why?
| | Sulfonamides | 1 | 2022 | 576 | 0.030 |
Why?
| | Glomerular Mesangium | 1 | 2017 | 21 | 0.030 |
Why?
| | Mitochondrial Turnover | 1 | 2017 | 5 | 0.030 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 198 | 0.030 |
Why?
| | Sodium-Glucose Transporter 2 | 1 | 2017 | 25 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 478 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2018 | 170 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2017 | 111 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2017 | 305 | 0.030 |
Why?
| | Feces | 1 | 2020 | 489 | 0.030 |
Why?
| | Hypolipidemic Agents | 1 | 2017 | 93 | 0.030 |
Why?
| | Albuminuria | 1 | 2017 | 185 | 0.030 |
Why?
| | Spleen | 1 | 2018 | 512 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2017 | 125 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 866 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 368 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 444 | 0.030 |
Why?
| | Longevity | 1 | 2017 | 174 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1261 | 0.030 |
Why?
| | Cell Line | 1 | 2021 | 2863 | 0.030 |
Why?
| | Triglycerides | 1 | 2017 | 510 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 661 | 0.030 |
Why?
| | Fibrosis | 1 | 2017 | 541 | 0.030 |
Why?
| | Carbachol | 1 | 2014 | 16 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 507 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1182 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1724 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2020 | 1439 | 0.030 |
Why?
| | Ceruletide | 1 | 2012 | 4 | 0.020 |
Why?
| | Amylases | 1 | 2012 | 17 | 0.020 |
Why?
| | Egtazic Acid | 1 | 2012 | 38 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2020 | 1983 | 0.020 |
Why?
| | Chymotrypsin | 1 | 2012 | 23 | 0.020 |
Why?
| | Cell Death | 1 | 2014 | 386 | 0.020 |
Why?
| | Adenoviridae | 1 | 2013 | 199 | 0.020 |
Why?
| | Dantrolene | 1 | 2012 | 5 | 0.020 |
Why?
| | NFATC Transcription Factors | 1 | 2012 | 94 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 873 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 716 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2904 | 0.020 |
Why?
| | Cell Polarity | 1 | 2012 | 139 | 0.020 |
Why?
| | Colorado | 1 | 2022 | 4599 | 0.020 |
Why?
| | Tacrolimus | 1 | 2012 | 199 | 0.020 |
Why?
| | Brain Neoplasms | 1 | 2020 | 1282 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4149 | 0.020 |
Why?
| | Salicylic Acid | 1 | 2009 | 8 | 0.020 |
Why?
| | Plants, Genetically Modified | 1 | 2009 | 15 | 0.020 |
Why?
| | Droughts | 1 | 2009 | 30 | 0.020 |
Why?
| | Plant Diseases | 1 | 2009 | 41 | 0.020 |
Why?
| | Dehydration | 1 | 2009 | 54 | 0.020 |
Why?
| | Protein Phosphatase 2C | 1 | 2008 | 15 | 0.020 |
Why?
| | Gene Library | 1 | 2009 | 121 | 0.020 |
Why?
| | NF-kappa B | 1 | 2012 | 684 | 0.020 |
Why?
| | Female | 3 | 2021 | 75814 | 0.020 |
Why?
| | Brain | 1 | 2020 | 2857 | 0.020 |
Why?
| | Infant | 1 | 2021 | 9820 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2009 | 607 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2017 | 2529 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 6951 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 22116 | 0.010 |
Why?
|
|
Wang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|